Abstract

Many 2-Cys-peroxiredoxins (2-Cys-Prxs) are dual-function proteins, either acting as peroxidases under non-stress conditions or as chaperones during stress. The mechanism by which 2-Cys-Prxs switch functions remains to be defined. Our work focuses on Leishmania infantum mitochondrial 2-Cys-Prx, whose reduced, decameric subpopulation adopts chaperone function during heat shock, an activity that facilitates the transition from insects to warm-blooded host environments. Here, we have solved the cryo-EM structure of mTXNPx in complex with a thermally unfolded client protein, and revealed that the flexible N-termini of mTXNPx form a well-resolved central belt that contacts and encapsulates the unstructured client protein in the center of the decamer ring. In vivo and in vitro cross-linking studies provide further support for these interactions, and demonstrate that mTXNPx decamers undergo temperature-dependent structural rearrangements specifically at the dimer-dimer interfaces. These structural changes appear crucial for exposing chaperone-client binding sites that are buried in the peroxidase-active protein.

Many 2-Cystein Peroxiredoxins (Prx) can either function as peroxidases or chaperones when exposed to stress. Here the authors present the structures of Leishmania infantum mitochondrial Prx alone and with a bound model client protein, use crosslinking to reveal interaction regions that stabilize the bound client, and provide insights into the mechanism by which Prx’s adopt chaperone activity.

Details

Title
Chaperone activation and client binding of a 2-cysteine peroxiredoxin
Author
Teixeira Filipa 1 ; Tse, Eric 2   VIAFID ORCID Logo  ; Castro, Helena 3 ; Makepeace Karl A T 4 ; Meinen, Ben A 5 ; Borchers, Christoph H 6 ; Poole, Leslie B 7 ; Bardwell, James C 5 ; Tomás, Ana M 8 ; Southworth, Daniel R 2 ; Jakob, Ursula 9 

 University of Michigan, Department of Molecular, Cellular and Developmental, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370); Universidade do Porto, i3S - Instituto de Investigação e Inovação em Saúde, Porto, Portugal (GRID:grid.5808.5) (ISNI:0000 0001 1503 7226); Universidade do Porto, IBMC - Instituto de Biologia Molecular e Celular, Porto, Portugal (GRID:grid.5808.5) (ISNI:0000 0001 1503 7226); Universidade do Porto, ICBAS – Instituto de Ciências Biomédicas Abel Salazar, Porto, Portugal (GRID:grid.5808.5) (ISNI:0000 0001 1503 7226) 
 Institute for Neurodegenerative Diseases, University of California, Department of Biochemistry and Biophysics, San Francisco, USA (GRID:grid.266102.1) (ISNI:0000 0001 2297 6811) 
 Universidade do Porto, i3S - Instituto de Investigação e Inovação em Saúde, Porto, Portugal (GRID:grid.5808.5) (ISNI:0000 0001 1503 7226); Universidade do Porto, IBMC - Instituto de Biologia Molecular e Celular, Porto, Portugal (GRID:grid.5808.5) (ISNI:0000 0001 1503 7226) 
 University of Victoria, Department of Biochemistry and Microbiology, Victoria, Canada (GRID:grid.143640.4) (ISNI:0000 0004 1936 9465); University of Victoria, Genome British Columbia Proteomics Centre, Victoria, Canada (GRID:grid.143640.4) (ISNI:0000 0004 1936 9465) 
 University of Michigan, Department of Molecular, Cellular and Developmental, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370); Howard Hughes Medical Institute, Ann Arbor, USA (GRID:grid.413575.1) (ISNI:0000 0001 2167 1581) 
 University of Victoria, Department of Biochemistry and Microbiology, Victoria, Canada (GRID:grid.143640.4) (ISNI:0000 0004 1936 9465); University of Victoria, Genome British Columbia Proteomics Centre, Victoria, Canada (GRID:grid.143640.4) (ISNI:0000 0004 1936 9465); Jewish General Hospital, Gerald Bronfman Department of Oncology, Montreal, Canada (GRID:grid.414980.0) (ISNI:0000 0000 9401 2774); Lady Davis Institute, Jewish General Hospital, Proteomics Centre, Segal Cancer Centre, Montreal, Canada (GRID:grid.414980.0) (ISNI:0000 0000 9401 2774) 
 Wake Forest School of Medicine, Department of Biochemistry, Winston-Salem, USA (GRID:grid.241167.7) (ISNI:0000 0001 2185 3318) 
 Universidade do Porto, i3S - Instituto de Investigação e Inovação em Saúde, Porto, Portugal (GRID:grid.5808.5) (ISNI:0000 0001 1503 7226); Universidade do Porto, IBMC - Instituto de Biologia Molecular e Celular, Porto, Portugal (GRID:grid.5808.5) (ISNI:0000 0001 1503 7226); Universidade do Porto, ICBAS – Instituto de Ciências Biomédicas Abel Salazar, Porto, Portugal (GRID:grid.5808.5) (ISNI:0000 0001 1503 7226) 
 University of Michigan, Department of Molecular, Cellular and Developmental, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370) 
Publication year
2019
Publication date
Dec 2019
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2177676862
Copyright
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.